<DOC>
	<DOCNO>NCT00675779</DOCNO>
	<brief_summary>The purpose study determine whether atorvastatin ( alone combination oral contraceptive ) effective treatment pelvic pain inflammatory response woman endometriosis .</brief_summary>
	<brief_title>Efficacy Study Atorvastatin Pelvic Pain Relief Women With Endometriosis</brief_title>
	<detailed_description />
	<mesh_term>Endometriosis</mesh_term>
	<mesh_term>Pelvic Pain</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Contraceptives , Oral</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Dacuronium</mesh_term>
	<criteria>inform write consent premenopausal woman age 1845 clinical sign symptom endometriosis minimum 3 month endometriosis confirm laparoscopy laparotomy within last 4 month 5 year ( preferably histological confirmation ) pain symptom moderate intensity ( dysmenorrhoea + dyspareunia + nonmenstrual pelvic pain &gt; 6 point Biberoglu &amp; Behrman scale [ 1981 ] ) clinical sign sexually transmit disease cancer ovary , adrenal , endometrium , uterine cervix , breast pregnancy lactation unexplained uterine/cervical bleeding hormonal therapy within last 3 month ( GnRH analogs 6 month ) irregular menses ( &gt; 35 day ) secondary amenorrhoea ( &gt; 3 month ) chronic disease affect pelvic abdominal cavity ( include PID , ulcerate colitis , Crohn 's disease , recurrent interstitial cystitis ) sexually transmit disease ( gonorrhoea , Chlamydia ) uncontrolled diabetes mellitus type I II , VTE contraindication medicine use study chronic therapy CYP3A4 inhibitor ( include ketoconazole , erythromycin others )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>endometriosis</keyword>
	<keyword>atorvastatin</keyword>
	<keyword>oral</keyword>
	<keyword>contraception</keyword>
	<keyword>pain</keyword>
	<keyword>relief</keyword>
	<keyword>pelvic pain woman endometriosis</keyword>
</DOC>